Viking Therapeutics Inc. (VKTX)
NASDAQ: VKTX
· Real-Time Price · USD
27.86
0.30 (1.09%)
At close: May 08, 2025, 3:59 PM
27.84
-0.07%
After-hours: May 08, 2025, 05:43 PM EDT
1.09% (1D)
| Bid | 27.8 |
| Market Cap | 3.13B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -128.24M |
| EPS (ttm) | -1.16 |
| PE Ratio (ttm) | -24.02 |
| Forward PE | -12.51 |
| Analyst | Buy |
| Ask | 28.09 |
| Volume | 2,852,556 |
| Avg. Volume (20D) | 4,681,059 |
| Open | 27.56 |
| Previous Close | 27.56 |
| Day's Range | 26.37 - 28.65 |
| 52-Week Range | 18.92 - 81.81 |
| Beta | 0.75 |
About VKTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VKTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for VKTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 week ago
+7.71%
Viking Therapeutics shares are trading higher afte...
Unlock content with
Pro Subscription
3 weeks ago
+10.58%
Viking Therapeutics shares are trading higher after Pfizer discontinued the development of danuglipron.
